为您找到相关结果约500个

你是不是要搜索 期刊实体瘤的疗效评价标准（RECIST 1.1) 点击跳转

Don't Throw Away RECIST 1.1 Quite Yet

Advances in oncological treatment: limitations of RECIST 1.1 criteria

Don't Throw Away RECIST 1.1 Quite Yet Response

Capturing Hyperprogressive Disease with Immune-Checkpoint Inhibitors Using RECIST 1.1 Criteria

Towards volumetric thresholds in RECIST 1.1: Therapeutic response assessment in hepatic metastases

RECIST 1.1 and lesion selection: How to deal with ambiguity at baseline?

Can we predict discordant RECIST 1.1 evaluations in double read clinical trials?

Comparison of tumor assessments using RECIST 1.1 and irRECIST, and association with overall survival

Follow-up of liver metastases: a comparison of deep learning and RECIST 1.1

Predicting Complete Cytoreduction in Ovarian Cancer Patients by RECIST 1.1 Criteria Following Neoadjuvant

Is RECIST Version 1.1 Reliable for Tumor Response Assessment in Metastatic Cancer?

Machine learning prediction of progression events in oncology RECIST 1.1 clinical trials

The alpha-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response

Validity of RECIST Version 1.1 for Response Assessment in Metastatic Cancer: A Prospective, Multireader

CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal

为您找到相关结果约500个

共500条页码: 1/34页15条/页